Ondansetron Tablet, Orally Disintegrating
Product Images NDC 60760-936

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 60760-936). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

60760-936 (Ondansetron 60760 936 10)

Packaging label for Ondansetron Orally Disintegrating Tablets USP 8 mg. The label indicates a quantity of 10 tablets, with storage instructions to keep at controlled room temperature 15-30°C (59-86°F). It includes manufacturing information by Glenmark Pharmaceuticals Inc. and packaging by St. Mary's Medical Park Pharmacy. The label features multiple repetitions of product and regulatory details, a barcode, and a two-dimensional matrix code.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure-base (Structure Base)

Chemical structure of ondansetron, showing its molecular framework including a bicyclic system with nitrogen atoms, a ketone group, and a methyl-substituted imidazole ring.*

FDA Label Image

Structure-hcl (Structure HCl)

Chemical structure of Ondansetron hydrochloride dihydrate, showing fused ring systems and functional groups characteristic of the active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.